Defy ADHD with Fish Oil and Omega-3 nutracueticals from Defy Medical

Attention Deficit Hyperactivity Disorder (ADHD) affects about 10 million children in the United States, many of whom take amphetamine-type drugs as treatment.

Studies show that children with ADHD have lower tissue levels of the omega-3 fatty acids eiosapentaenoic acid (EPA) and docosahexaeinic acid (DHA) as compared to kids without ADHD.

New Data: To determine the effects of fish oils on children with ADHD, 90 children ages 7-12 were given either:

  • An EPA-rich fish oil (1,109mg EPA/108mg DHA)
  • A DHA-rich fish oil (264mg EPA/ 1,032 DHA)
  • A safflower oil providing 1,467mg linoleic acid

Researchers found that an increased red blood cell level of DHA was associated with improved reading and lower parent ratings of oppositional behavior. Furthermore, when they examined a subgroup of 17 children with learning difficulties: increased DHA was associated with lower parent ratings of oppositional behavior, hyperactivity, restlessness, and other ADHD symptoms.

Commentary: The ratio of DHA to EPA in a supplement likely does not matter. A fish oil providing, say, a 2:1 EPA to DHA ratio could show similar results, because 3,000mg dosage of such a product would provide the same amount of DHA used in the study.

Contact Defy Medical to find out more about Omega-3 nutracueticals available to patients.

Share